Allergan Inc.’s consolidated patent infringement actions against Barr Laboratories, Inc. and Sandoz, Inc. remain pending.
In March 2009, the Company received a paragraph 4 invalidity and non-infringement Hatch-Waxman Act certification from…
A claims construction hearing in Amgen Inc.’s patent infringement lawsuit against Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd. and Barr Laboratories, Inc. is set for Jan. 25 and Jan.…
Allergan Inc.’s patent infringement complaint against Barr Laboratories, Inc., is pending in the U.S. District Court for the District of Delaware.
In March 2009, the Company received a paragraph 4 invalidity…
SmithKline Beecham’s patent infringement case against Barr Laboratories is in the discovery phase, according to GlaxoSmithKline Plc’s Form 20-F filed with the U.S. Securities and Exchange Commission on March 4,…
A claims construction hearing in Amgen Inc.’s patent infringement lawsuit against Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd. and Barr Laboratories, Inc. is set for Sept. 16 and Sept.…
The 30-month stay in the RAZADYNE(R) cases filed by Johnson & Johnson’s subsidiary, Ortho-McNeil Pharmaceutical Inc., expires in late August 2008.
In the action against Barr Laboratories, Inc. and AlphaPharm with…
Johnson & Johnson’s subsidiary, Ortho-McNeil Pharmaceutical Inc., intends to appeal the summary judgment decision invalidating the claims of U.S. Patent No. 39,221 (reissue patent).
The ‘221 patent claims combinations of acetaminophen…
Settlement discussions between Johnson & Johnson’s subsidiary, Ortho Women’s Health & Urology, and Barr Laboratories, Inc. regarding the ORTHO TRICYCLEN(R) LO patent are still underway.
Ortho Women’s is a Division of…